Risk Factors for Drug-resistant Streptococcus pneumoniae and Antibiotic Prescribing Practices in Outpatient Community-acquired Pneumonia

被引:32
|
作者
Jenkins, Timothy C. [1 ,2 ,6 ,7 ]
Sakai, Joy [6 ]
Knepper, Bryan C. [3 ]
Swartwood, Claire J. [4 ,8 ]
Haukoos, Jason S. [5 ,9 ,10 ]
Long, Jeremy A. [1 ,6 ]
Price, Connie S. [1 ,2 ,6 ,7 ]
Burman, William J. [1 ,2 ,6 ,7 ]
机构
[1] Denver Hlth Med Ctr, Dept Med, Denver, CO USA
[2] Denver Hlth Med Ctr, Div Infect Dis, Denver, CO USA
[3] Denver Hlth Med Ctr, Dept Patient Safety & Qual, Denver, CO USA
[4] Denver Hlth Med Ctr, Dept Pharm, Denver, CO USA
[5] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA
[6] Univ Colorado Denver, Dept Med, Aurora, CO USA
[7] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA
[8] Univ Colorado Denver, Dept Pharm, Aurora, CO USA
[9] Univ Colorado Denver, Dept Emergency Med, Aurora, CO USA
[10] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA
关键词
ANTIMICROBIAL RESISTANCE; FLUOROQUINOLONES; EMERGENCE;
D O I
10.1111/j.1553-2712.2012.01365.x
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Due to antimicrobial resistance in Streptococcus pneumoniae, national guidelines recommend a respiratory fluoroquinolone or combination antimicrobial therapy for outpatient treatment of community-acquired pneumonia (CAP) associated with risk factors for drug-resistant S. pneumoniae (DRSP). The objectives of this study were to assess the prevalence of these risk factors and antibiotic prescribing practices in cases of outpatient CAP treated in the acute care setting. Methods: This was a retrospective cohort study of adult outpatients treated for CAP in the emergency department (ED) or urgent care center of an urban, academic medical center from May 1, 2009, through October 31, 2009, and comparison of antibiotic therapy in cases with and without DRSP risk factors. Results: Of 175 patients, 90 (51%) had at least one DRSP risk factor, most commonly asthma (n = 28, 16%), alcohol abuse (n = 24, 14%), diabetes mellitus (n = 18, 10%), chronic obstructive pulmonary disease (n = 16, 9%), age > 65 years (n = 16, 9%), and use of antibiotics within 3 months (15, 9%). Antibiotic prescriptions were similar among cases with and without DRSP risk factors: a macrolide (62% vs. 59%, respectively, p = 0.65), doxycycline (27% vs. 28%, p = 0.82), or a respiratory fluoroquinolone (9% vs. 9%, p = 0.90). Concordance with national guideline treatment recommendations was significantly lower in cases with DRSP risk factors (9% vs. 87%, p < 0.0001). Conclusions: DRSP risk factors were present in approximately half of outpatient CAP cases treated in the acute care setting; however, guideline-concordant antibiotic therapy was infrequent. Strict adherence to current guidelines would substantially increase use of fluoroquinolones or combination therapy. Whether the potential risks associated with these broad-spectrum regimens are justified by improved clinical outcomes requires further study. ACADEMIC EMERGENCY MEDICINE 2012; 19: 703-706 (C) 2012 by the Society for Academic Emergency Medicine
引用
收藏
页码:703 / 706
页数:4
相关论文
共 50 条
  • [31] Validation of a Prediction Score for Drug-Resistant Microorganisms in Community-acquired Pneumonia
    Ceccato, Adrian
    Mendez, Raul
    Ewig, Santiago
    de la Torre, Mari C.
    Cilloniz, Catia
    Gabarrus, Albert
    Prina, Elena
    Ranzani, Otavio T.
    Ferrer, Miquel
    Almirall, Jordi
    Menendez, Rosario
    Torres, Antoni
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (02) : 257 - 265
  • [32] Community-acquired pneumonia due to drug-resistant Enterobacteriaceae: A global perspective
    Aston, Stephen J.
    Wootton, Daniel G.
    RESPIROLOGY, 2020, 25 (05) : 468 - 469
  • [33] Canadian Pediatricians' Prescribing Practices for Community-Acquired Pneumonia
    Pernica, Jeffrey M.
    Mah, Jordan K.
    Kam, April J.
    CLINICAL PEDIATRICS, 2014, 53 (05) : 493 - 496
  • [34] Extended-spectrum antibiotics for community-acquired pneumonia with a low risk for drug-resistant pathogens
    Kobayashi, Hironori
    Shindo, Yuichiro
    Kobayashi, Daisuke
    Sakakibara, Toshihiro
    Murakami, Yasushi
    Yagi, Mitsuaki
    Matsuura, Akinobu
    Sato, Kenta
    Matsui, Kota
    Emoto, Ryo
    Yagi, Tetsuya
    Saka, Hideo
    Matsui, Shigeyuki
    Hasegawa, Yoshinori
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 124 : 124 - 132
  • [35] Antibiotic Resistance in Community-Acquired Pneumonia Caused by Streptococcus pneumoniae, Methicillin-Resistant Staphylococcus aureus, and Acinetobacter baumannii
    Ho, Pak-Leung
    Cheng, Vincent Chi-Chung
    Chu, Chung-Ming
    CHEST, 2009, 136 (04) : 1119 - 1127
  • [36] Retrospective cohort analysis of outpatient antibiotic prescribing for community-acquired pneumonia in Canadian older adults
    Saatchi, Ariana
    Reid, Jennifer N.
    Shariff, Salimah Z.
    Povitz, Marcus
    Silverman, Michael
    Patrick, David M.
    Morris, Andrew M.
    Mccormack, James
    Haverkate, Manon R.
    Marra, Fawziah
    PLOS ONE, 2023, 18 (10):
  • [37] Determining the contribution of Streptococcus pneumoniae to community-acquired pneumonia in Australia
    Yin, J. Kevin
    Jayasinghe, Sanjay H.
    Charles, Patrick G.
    King, Catherine
    Chiu, Clayton K.
    Menzies, Robert I.
    McIntyre, Peter B.
    MEDICAL JOURNAL OF AUSTRALIA, 2017, 207 (09) : 396 - 400
  • [38] Risk Factors Associated With Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia in Azerbaijan Republic
    Sadigov, Alizamin
    Agayeva, Kamala
    CHEST, 2017, 152 (04) : 123A - 123A
  • [39] Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia
    Bohte, R
    Hermans, J
    vandenBroek, PJ
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (03) : 201 - 205
  • [40] Carriage of Streptococcus pneumoniae in adults hospitalised with community-acquired pneumonia
    Lansbury, Louise
    McKeever, Tricia M.
    Lawrence, Hannah
    Pick, Harry
    Baskaran, Vadsala
    Edwards-Pritchard, Rochelle C.
    Ashton, Deborah
    Rodrigo, Chamira
    Daniel, Priya
    Litt, David
    Eletu, Seyi
    Parmar, Hanshi
    Sheppard, Carmen L.
    Ladhani, Shamez
    Trotter, Caroline
    Lim, Wei Shen
    JOURNAL OF INFECTION, 2024, 89 (05)